⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NAGE News
Niagen Bioscience, Inc. Common Stock
Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026
businesswire.com
NAGE
Functional Wellness Stocks Explode as $179 Billion Beverage Market Ditches Sugar for Science
globenewswire.com
CGC
NAGE
SBEV
ZVIA
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
globenewswire.com
LEXX
WST
NAGE
PM
Niagen Bioscience Expands HSA/FSA Access for Tru Niagen ®, the Leading NAD+ Supplement in the U.S.*
businesswire.com
NAGE
Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from Queen’s University Belfast
businesswire.com
NAGE
Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID
businesswire.com
NAGE
Niagen Bioscience Announces $10 Million Share Repurchase Program
businesswire.com
NAGE
Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook
businesswire.com
NAGE